Box score
Alzheon, Inc.
Reported $78.8M sold in a new Form D filed September 10, 2026 (Framingham, Massachusetts).
- Biggest raise
- $78.8M filed Sep 10, 2026
- League
- Bio & Health Biotechnology
- Based in
- Framingham, Massachusetts
- Season rank
- #22 of 1,121 in the Bio & Health League; #321 of 10,745 overall (2026)
- Entity
- Corporation
Form D filings since 2024 4
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-09-10 | New notice | $78.8M | $500M | SEC |
| 2025-02-10 | Amendment | $126M | $150M | SEC |
| 2025-01-02 | Amendment | $125M | $125M | SEC |
| 2024-03-12 | New notice | $17.2M | $50M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1582636.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Ratio Therapeutics, Inc. | Bio & Health | $70M |
| 2 | Superluminal Medicines, Inc. | Bio & Health | $65.5M |
| 3 | Stipple Bio, Inc. | Bio & Health | $65.1M |
| 4 | Terrestrial Bio, Inc. | Bio & Health | $57.3M |
| 5 | Typewriter Therapeutics, Inc. rookie | Bio & Health | $56.3M |
| 6 | Cue Biopharma, Inc. | Bio & Health | $50M |